Wan R - Search Results

1

Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer.

Wang Z, Fu S, Zhao J, Zhao W, Shen Z, Wang D, Duan J, Bai H, Wan R, Yu J, Wang S, Chen H, Chen B, Wang L, Wang J. Wang Z, et al. Among authors: wan r. Cancer Lett. 2019 Jan;440-441:180-188. doi: 10.1016/j.canlet.2018.10.014. Epub 2018 Oct 19. Cancer Lett. 2019. PMID: 30347283

2

Efficacy and safety of weekly intravenous nanoparticle albumin-bound paclitaxel for non-small cell lung cancer patients who have failed at least two prior systemic treatments.

Duan J, Hao Y, Wan R, Yu S, Bai H, An T, Zhao J, Wang Z, Zhuo M, Wang J. Duan J, et al. Among authors: wan r. Thorac Cancer. 2017 May;8(3):138-146. doi: 10.1111/1759-7714.12413. Epub 2017 Mar 17. Thorac Cancer. 2017. PMID: 28304139 Free PMC article.

3

Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer.

Wan R, Wang Z, Lee JJ, Wang S, Li Q, Tang F, Wang J, Sun Y, Bai H, Wang D, Zhao J, Duan J, Zhuo M, An T, Wu M, Chen Z, Yang Z, Wang J. Wan R, et al. J Thorac Oncol. 2017 Sep;12(9):1376-1387. doi: 10.1016/j.jtho.2017.05.011. Epub 2017 May 26. J Thorac Oncol. 2017. PMID: 28552765 Free article.

4

[Clinical Characteristics of Lung Cancer with Pancreatic Metastases].

Duan J, Wan R, Shen J, Liu X, Wang J, Zhao J, Wu M, Yang L, An T, Guo Q. Duan J, et al. Among authors: wan r. Zhongguo Fei Ai Za Zhi. 2017 Aug 20;20(8):511-515. doi: 10.3779/j.issn.1009-3419.2017.08.02. Zhongguo Fei Ai Za Zhi. 2017. PMID: 28855030 Free PMC article. Chinese.

5

Prediction of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer by Serum Metabolomic Profiling.

Tian Y, Wang Z, Liu X, Duan J, Feng G, Yin Y, Gu J, Chen Z, Gao S, Bai H, Wan R, Jiang J, Liu J, Zhang C, Wang D, Han J, Zhang X, Cai L, He J, Wang J. Tian Y, et al. Among authors: wan r. Clin Cancer Res. 2018 May 1;24(9):2100-2109. doi: 10.1158/1078-0432.CCR-17-2855. Epub 2018 Feb 6. Clin Cancer Res. 2018. PMID: 29437793

6

Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade.

Wang Z, Zhao J, Wang G, Zhang F, Zhang Z, Zhang F, Zhang Y, Dong H, Zhao X, Duan J, Bai H, Tian Y, Wan R, Han M, Cao Y, Xiong L, Liu L, Wang S, Cai S, Mok TSK, Wang J. Wang Z, et al. Among authors: wan r. Cancer Res. 2018 Nov 15;78(22):6486-6496. doi: 10.1158/0008-5472.CAN-18-1814. Epub 2018 Aug 31. Cancer Res. 2018. PMID: 30171052

7

Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial.

Duan JC, Wang ZJ, Lin L, Li JL, Wang Y, Bai H, Hu XS, Liu YT, Hao XZ, Wang HY, Wan R, Wang X, Wang J. Duan JC, et al. Among authors: wan r. Invest New Drugs. 2019 Aug;37(4):731-737. doi: 10.1007/s10637-019-00735-1. Epub 2019 Feb 1. Invest New Drugs. 2019. PMID: 30706337 Clinical Trial.

8

TCR Repertoire Diversity of Peripheral PD-1⁺CD8⁺ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non-Small Cell Lung Cancer.

Han J, Duan J, Bai H, Wang Y, Wan R, Wang X, Chen S, Tian Y, Wang D, Fei K, Yao Z, Wang S, Lu Z, Wang Z, Wang J. Han J, et al. Among authors: wan r. Cancer Immunol Res. 2020 Jan;8(1):146-154. doi: 10.1158/2326-6066.CIR-19-0398. Epub 2019 Nov 12. Cancer Immunol Res. 2020. PMID: 31719056

9

Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors.

Wang Z, Duan J, Wang G, Zhao J, Xu J, Han J, Zhao Z, Zhao J, Zhu B, Zhuo M, Sun J, Bai H, Wan R, Wang X, Fei K, Wang S, Zhao X, Zhang Y, Huang M, Huang D, Qi C, Gao C, Bai Y, Dong H, Xiong L, Tian Y, Wang D, Xu C, Wang W, Li J, Hu X, Cai S, Wang J. Wang Z, et al. Among authors: wan r. J Thorac Oncol. 2020 Apr;15(4):556-567. doi: 10.1016/j.jtho.2019.12.001. Epub 2019 Dec 12. J Thorac Oncol. 2020. PMID: 31843683 Free article.

10

A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients.

Tian Y, Xu J, Chu Q, Duan J, Zhang J, Bai H, Yang Z, Fang W, Cai L, Wan R, Fei K, He J, Gao S, Zhang L, Wang Z, Wang J. Tian Y, et al. Among authors: wan r. BMC Med. 2020 Aug 26;18(1):232. doi: 10.1186/s12916-020-01694-8. BMC Med. 2020. PMID: 32843031 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,149 results

Search Page

Filters